# FDA Inspection 1070480 - Hangzhou Huadong Med. Group Kangrun Pharmaceutical Co Ltd - September 19, 2018

Source: https://www.keypedia.com/records/fda_inspections/hangzhou-huadong-med-group-kangrun-pharmaceutical-co-ltd/65cfdc2d-5c45-43c3-aaf4-c102f780ac1e
Source feed: FDA_Inspections

> FDA Inspection 1070480 for Hangzhou Huadong Med. Group Kangrun Pharmaceutical Co Ltd on September 19, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1070480
- Company Name: Hangzhou Huadong Med. Group Kangrun Pharmaceutical Co Ltd
- Inspection Date: 2018-09-19
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 912077 - 2015-01-22](https://www.keypedia.com/records/fda_inspections/hangzhou-huadong-med-group-kangrun-pharmaceutical-co-ltd/01a6e982-7919-4814-b996-e2488ee267cb)

Company: https://www.keypedia.com/companies/hangzhou-huadong-med-group-kangrun-pharmaceutical-co-ltd/43c8c39d-6293-43ae-89ed-163cb147325a

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c